Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Erin Alexis Dean

Title(s)Assistant Health Sciences Professor, Medicine
SchoolSchool of Medicine
Address1001 Health Sciences Road
Irvine CA 92697-3950
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    UC Irvine, Irvine, CABSBiomedical Engineering, Premedical
    University of South Florida, Tampa, FLMDMedicine
    University of South Florida , Tampa, FLInternal Medicine Residency
    Moffitt Cancer Center/ University of South Florida , Tampa, FLHematology/Oncology Fellowship
    Moffitt Cancer Center , Tampa, FLBlood and Marrow/Cellular Immunotherapy Fellowship

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Soluble B-cell maturation antigen as a serum marker of MRD in patients with multiple myeloma. Front Oncol. 2025; 15:1631511. Dean EA, Li DM, Lin T, Sampson EM, Seifert RP, Hsu JW, Hiemenz JW, Wingard JR. PMID: 40994952; PMCID: PMC12454026.
      View in: PubMed   Mentions:
    2. Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphoma. Blood Cancer J. 2025 Aug 26; 15(1):144. Winkelmann M, Raj SS, Jain MD, Iacoboni G, Müller F, Hansmann L, Corona M, Luna A, Jhaveri K, Shah GL, Scordo M, Mohammad T, Dean EA, Sheikh GT, Kunz WG, Tix T, Bücklein VL, Bedmutha A, Leithner D, von Bergwelt-Baildon M, Boardman AP, Palomba ML, Park JH, Salles G, Perales MA, Schöder H, Subklewe M, Barba P, Locke FL, Shouval R, Rejeski K. PMID: 40858552; PMCID: PMC12381142.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Case Report: Reactive T-cell large granular lymphocytes in the bone marrow of a patient with relapsed/refractory multiple myeloma receiving teclistamab. Front Oncol. 2025; 15:1630929. Dean EA, Yang LJ, Seifert RP, Wingard JR. PMID: 40842590; PMCID: PMC12364682.
      View in: PubMed   Mentions:
    4. Prompt Autologous Hematopoietic Stem Cell Transplant in Patients With Large B-Cell Lymphoma Is Associated With Lower Rates of Progression of Disease Prior to Transplant. EJHaem. 2025 Aug; 6(4):e70108. Dean EA, Lin RY, Lin T, Li DM, Hsu JW, Hiemenz JW, Lynch JW, Wingard JR. PMID: 40708709; PMCID: PMC12288611.
      View in: PubMed   Mentions:
    5. Gut Faecalibacterium abundance in patients with plasma cell disorders is associated with survival after autologous HSCT. Blood Neoplasia. 2025 Aug; 2(3):100114. Dean EA, Roy A, Lin RY, Gharaibeh RZ, Li DM, Gauthier J, Jobin C, Wingard JR. PMID: 40735351; PMCID: PMC12304682.
      View in: PubMed   Mentions: Translation:CTClinical Trials
    6. Radiomic features of PET/CT imaging of large B cell lymphoma lesions predicts CAR T cell therapy efficacy. Front Oncol. 2024; 14:1485039. Balagurunathan Y, Wei Z, Qi J, Thompson Z, Dean E, Lu H, Vardhanabhuti S, Corallo S, Choi JW, Kim JJ, Mattie M, Jain M, Locke FL. PMID: 39659779; PMCID: PMC11629080.
      View in: PubMed   Mentions: 1  
    7. A phase ib clinical trial of oral ciprofloxacin and etoposide in subjects with resistant acute myeloid leukemia. Leuk Lymphoma. 2024 Oct; 65(10):1502-1510. Gera K, Cline C, Al-Mansour Z, Medvec A, Lee JH, Galochkina Z, Hsu J, Hiemenz J, Farhadfar N, Dean EA, Wingard JR, Brown R. PMID: 38841781.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    8. Baseline Serum Inflammatory Proteins Predict Poor CAR T Outcomes in Diffuse Large B-cell Lymphoma. Blood Cancer Discov. 2024 Mar 01; 5(2):106-113. Faramand RG, Lee SB, Jain MD, Cao B, Wang X, Rejeski K, Subklewe M, Fahrmann JF, Saini NY, Hanash SM, Kang YP, Chang D, Rodriguez PC, Dean EA, Nishihori T, Shah BD, Lazaryan A, Chavez J, Khimani F, Pinilla-Ibarz JA, Dam M, Reid KM, Corallo SA, Menges M, Hidalgo Vargas M, Mandula JK, Holliday BA, Bachmeier CA, Speth K, Song Q, Mattie M, Locke FL, Davila ML. PMID: 38194367; PMCID: PMC10905320.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    9. Exacerbations of Persistent Neurotoxicity following Axicabtagene Ciloleucel in a Patient with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Case Report. Case Rep Oncol. 2024 Jan-Dec; 17(1):75-81. Fenton GA, Dean EA. PMID: 38196817; PMCID: PMC10776132.
      View in: PubMed   Mentions:
    10. Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion. Sci Adv. 2023 09 22; 9(38):eadg3919. Rejeski K, Perez A, Iacoboni G, Blumenberg V, Bücklein VL, Völkl S, Penack O, Albanyan O, Stock S, Müller F, Karschnia P, Petrera A, Reid K, Faramand R, Davila ML, Modi K, Dean EA, Bachmeier C, von Bergwelt-Baildon M, Locke FL, Bethge W, Bullinger L, Mackensen A, Barba P, Jain MD, Subklewe M. PMID: 37738350; PMCID: PMC10516499.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    11. Circulating tumor DNA adds specificity to PET after axicabtagene ciloleucel in large B-cell lymphoma. Blood Adv. 2023 08 22; 7(16):4608-4618. Dean EA, Kimmel GJ, Frank MJ, Bukhari A, Hossain NM, Jain MD, Dahiya S, Miklos DB, Altrock PM, Locke FL. PMID: 37126659; PMCID: PMC10448428.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    12. Repeatability of metabolic tumor burden and lesion glycolysis between clinical readers. Front Immunol. 2023; 14:994520. Choi JW, Dean EA, Lu H, Thompson Z, Qi J, Krivenko G, Jain MD, Locke FL, Balagurunathan Y. PMID: 36875072; PMCID: PMC9975754.
      View in: PubMed   Mentions: 6     Fields:    Translation:Cells
    13. Pattern of brexucabtagene autoleucel-related neurotoxicity on magnetic resonance imaging of the brain in a patient with relapsed/refractory B-cell acute lymphoblastic leukemia and prior leptomeningeal disease. Radiol Case Rep. 2023 Mar; 18(3):1093-1098. Dean EA, Peters KR, Adams CB, Hiemenz JW. PMID: 36660565; PMCID: PMC9842530.
      View in: PubMed   Mentions:
    14. Viral Clearance with Neutrophil Recovery in a Patient with Active COVID-19 Infection and Refractory Acute Myeloid Leukemia Who Underwent Successful Reinduction with Cytarabine/Idarubicin. Case Rep Oncol. 2022 May-Aug; 15(2):705-712. Dean EA, Brown RA, Kaur P, Casaus DV. PMID: 36157697; PMCID: PMC9459561.
      View in: PubMed   Mentions: 2  
    15. Increased Infections and Delayed CD4+ T Cell but Faster B Cell Immune Reconstitution after Post-Transplantation Cyclophosphamide Compared to Conventional GVHD Prophylaxis in Allogeneic Transplantation. Transplant Cell Ther. 2021 11; 27(11):940-948. Khimani F, Ranspach P, Elmariah H, Kim J, Whiting J, Nishihori T, Locke FL, Perez Perez A, Dean E, Mishra A, Perez L, Lazaryan A, Jain MD, Nieder M, Liu H, Faramand R, Hansen D, Alsina M, Ochoa L, Davila M, Anasetti C, Pidala J, Bejanyan N. PMID: 34329754.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    16. Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional Trial. J Clin Oncol. 2021 09 20; 39(27):3034-3043. Frank MJ, Hossain NM, Bukhari A, Dean E, Spiegel JY, Claire GK, Kirsch I, Jacob AP, Mullins CD, Lee LW, Kong KA, Craig J, Mackall CL, Rapoport AP, Jain MD, Dahiya S, Locke FL, Miklos DB. PMID: 34133196; PMCID: PMC10166351.
      View in: PubMed   Mentions: 77     Fields:    Translation:Humans
    17. Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma. Blood. 2021 05 13; 137(19):2621-2633. Jain MD, Zhao H, Wang X, Atkins R, Menges M, Reid K, Spitler K, Faramand R, Bachmeier C, Dean EA, Cao B, Chavez JC, Shah B, Lazaryan A, Nishihori T, Hussaini M, Gonzalez RJ, Mullinax JE, Rodriguez PC, Conejo-Garcia JR, Anasetti C, Davila ML, Locke FL. PMID: 33512407; PMCID: PMC8120145.
      View in: PubMed   Mentions: 135     Fields:    Translation:HumansCells
    18. Impact of Total Body Irradiation-Based Myeloablative Conditioning Regimens in Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: Systematic Review and Meta-Analysis. Transplant Cell Ther. 2021 07; 27(7):620.e1-620.e9. Khimani F, Dutta M, Faramand R, Nishihori T, Perez AP, Dean E, Nieder M, Perez L, Mishra A, Elmariah H, Davila M, Ochoa L, Alsina M, Lazaryan A, Bejanyan N, Hansen D, Jain M, Locke F, Liu H, Pidala J, Shah B, Mhaskar R. PMID: 33798768.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    19. Diffuse Intrasinusoidal Hepatic Metastasis from Breast Cancer Presenting as Liver Failure: Effective and Rapid Treatment with Weekly Low-Dose Adriamycin. Am J Case Rep. 2020 Sep 02; 21:e924141. Afiat TN, Hembree TN, Dean EA, Araujo C, Pena LR, Rosa M, Han HS, Hendrix K, Ramsakal A. PMID: 32877389; PMCID: PMC7491943.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    20. High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma. Blood Adv. 2020 07 28; 4(14):3268-3276. Dean EA, Mhaskar RS, Lu H, Mousa MS, Krivenko GS, Lazaryan A, Bachmeier CA, Chavez JC, Nishihori T, Davila ML, Khimani F, Liu HD, Pinilla-Ibarz J, Shah BD, Jain MD, Balagurunathan Y, Locke FL. PMID: 32702097; PMCID: PMC7391155.
      View in: PubMed   Mentions: 137     Fields:    Translation:Humans
    21. Response to Multi-Line Chemotherapy in Non-Serous Epithelial Ovarian Cancer. J Obstet Gynaecol Can. 2020 Oct; 42(10):1217-1222. Altman AD, Lambert P, Dean E, Robinson C, Nachtigal MW, Kean S. PMID: 32694071.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Examining the Selection Criteria of Neoadjuvant Chemotherapy Patients. J Obstet Gynaecol Can. 2018 05; 40(5):595-603. Mayba J, Lambert P, Turner D, Lotocki R, Dean E, Popowich S, Altman AD, Nachtigal MW, Manitoba Ovarian Cancer Outcomes (MOCO) Study Group. PMID: 29276164.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    23. Predictors of overall survival among patients treated with sirolimus/tacrolimus vs methotrexate/tacrolimus for GvHD prevention. Bone Marrow Transplant. 2017 Jul; 52(7):1003-1009. Khimani F, Kim J, Chen L, Dean E, Rizk V, Betts B, Nishihori T, Locke F, Mishra A, Perez L, Ayala E, Kharfan-Dabaja M, Nieder M, Fernandez H, Anasetti C, Pidala J. PMID: 28368376; PMCID: PMC7771296.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    24. Diagnostic and referral intervals for Manitoba women with epithelial ovarian cancer - the Manitoba Ovarian Cancer Outcomes (MOCO) study group: a retrospective cross-sectional study. CMAJ Open. 2017 Jan-Mar; 5(1):E116-E122. Love AJ, Lambert P, Turner D, Lotocki R, Dean E, Popowich S, Altman AD, Nachtigal MW. PMID: 28401127; PMCID: PMC5378539.
      View in: PubMed   Mentions: 2     Fields:    
    25. Postoperative Infection in the Setting of Massive Intraoperative Blood Loss. J Obstet Gynaecol Can. 2016 12; 38(12):1110-1113. Leylek M, Poliquin V, Al-Wazzan A, Dean E, Altman AD. PMID: 27986185.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    26. A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors. Ann Oncol. 2016 12; 27(12):2268-2274. Soria JC, Gan HK, Blagden SP, Plummer R, Arkenau HT, Ranson M, Evans TR, Zalcman G, Bahleda R, Hollebecque A, Lemech C, Dean E, Brown J, Gibson D, Peddareddigari V, Murray S, Nebot N, Mazumdar J, Swartz L, Auger KR, Fleming RA, Singh R, Millward M. PMID: 27733373.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansCTClinical Trials
    27. An Adaptive Study to Determine the Optimal Dose of the Tablet Formulation of the PARP Inhibitor Olaparib. Target Oncol. 2016 06; 11(3):401-15. Mateo J, Moreno V, Gupta A, Kaye SB, Dean E, Middleton MR, Friedlander M, Gourley C, Plummer R, Rustin G, Sessa C, Leunen K, Ledermann J, Swaisland H, Fielding A, Bannister W, Nicum S, Molife LR. PMID: 27169564.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCTClinical Trials
    28. Hormone Use After Nonserous Epithelial Ovarian Cancer: Overall and Disease-Free Survival. Obstet Gynecol. 2016 05; 127(5):837-847. Power L, Lefas G, Lambert P, Kim D, Evaniuk D, Lotocki R, Dean E, Nachtigal MW, Altman AD. PMID: 27054933.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    29. A phase I, dose escalation, pharmacodynamic, pharmacokinetic, and food-effect study of α2 integrin inhibitor E7820 in patients with advanced solid tumors. Invest New Drugs. 2016 06; 34(3):329-37. Milojkovic Kerklaan B, Slater S, Flynn M, Greystoke A, Witteveen PO, Megui-Roelvink M, de Vos F, Dean E, Reyderman L, Ottesen L, Ranson M, Lolkema MP, Plummer R, Kristeleit R, Evans TR, Schellens JH. PMID: 27039386.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    30. Pure Immature Teratoma of the Ovary in Adults: Thirty-Year Experience of a Single Tertiary Care Center. Int J Gynecol Cancer. 2015 Nov; 25(9):1616-22. Alwazzan AB, Popowich S, Dean E, Robinson C, Lotocki R, Altman AD. PMID: 26332392; PMCID: PMC4623850.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    Erin's Networks
    Concepts (115)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (1)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCI Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-18-gb39b692b on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California